Antitumor and antimetastatic activity of interleukin 12 against murine tumors. - Wikidata - wikimedia - TriplyDB

Antitumor and antimetastatic activity of interleukin 12 against murine tumors.

Antitumor and antimetastatic activity of interleukin 12 against murine tumors.

http://www.wikidata.org/entity/Q41906195

about

A novel strategy for evasion of NK cell immunity by tumours expressing core2 O-glycans Loss of tumor progression locus 2 (tpl2) enhances tumorigenesis and inflammation in two-stage skin carcinogenesis Current and Future Gene Therapy for Malignant Gliomas Antiangiogenic gene therapy of cancer: recent developments IL-12 Production Induced by Agaricus blazei Fraction H (ABH) Involves Toll-like Receptor (TLR)Novel immunotherapeutic approaches to the treatment of urothelial carcinoma Cytokine-Induced Modulation of Colorectal Cancer Interleukin 12: still a promising candidate for tumor immunotherapy?In-situ tumor vaccination: Bringing the fight to the tumor Genetic engineering with T cell receptors Signal transducer and activator of transcription 4 in liver diseases Ustekinumab in treatment of Crohn's disease: design, development, and potential place in therapy PD-1 inhibition and treatment of advanced melanoma-role of pembrolizumab Review: Application of Nanoparticles in Urothelial Cancer of the Urinary Bladder A novel copper chelate modulates tumor associated macrophages to promote anti-tumor response of T cells Mirtazapine inhibits tumor growth via immune response and serotonergic system Mathematical modeling of interleukin-27 induction of anti-tumor T cells response Immune response of healthy horses to DNA constructs formulated with a cationic lipid transfection reagent Focused ultrasound-induced blood-brain barrier opening to enhance interleukin-12 delivery for brain tumor immunotherapy: a preclinical feasibility study.Role of CXCR3 ligands in IL-7/IL-7R alpha-Fc-mediated antitumor activity in lung cancer.Construction of a regulable gene therapy vector targeting for hepatocellular carcinoma.Cloning and characterization of an adenoviral vector for highly efficient and doxycycline-suppressible expression of bioactive human single-chain interleukin 12 in colon cancer.Combining cytotoxic and immune-mediated gene therapy to treat brain tumors IL-12 can target human lung adenocarcinoma cells and normal bronchial epithelial cells surrounding tumor lesions.Non-redundant role for IL-12 and IL-27 in modulating Th2 polarization of carcinoembryonic antigen specific CD4 T cells from pancreatic cancer patients Enhanced antitumor effects by combining an IL-12/anti-DNA fusion protein with avelumab, an anti-PD-L1 antibody.Expression, engineering and characterization of the tumor-targeting heterodimeric immunocytokine F8-IL12.Tumor Therapy Applying Membrane-bound Form of Cytokines.The role of interleukin-12 in preserving the graft-versus-leukemia effect of allogeneic CD8 T cells independently of GVHD.IL-12 and IL-27 sequential gene therapy via intramuscular electroporation delivery for eliminating distal aggressive tumors.The immunocytokine NHS-IL12 as a potential cancer therapeutic Strategy of liver-directed gene therapy: present status and future prospects.Rapid release of cytoplasmic IL-15 from tumor-associated macrophages is an initial and critical event in IL-12-initiated tumor regression.Additive antitumoral effect of interleukin-12 gene therapy and chemotherapy in the treatment of urothelial bladder cancer in vitro and in vivo.Immunomodulation by thalidomide and thalidomide analogues Dual roles of sialyl Lewis X oligosaccharides in tumor metastasis and rejection by natural killer cells.IL-23/IL-27 Ratio in Peripheral Blood of Patients with Breast Cancer.Construction of a single-chain interleukin-12-expressing retroviral vector and its application in cytokine gene therapy against experimental coccidioidomycosis.The role of interleukin-12 and interferon-gamma in GVHD and GVL.Increased levels of C-C chemokine RANTES in asbestos exposed workers and in malignant mesothelioma patients from an hyperendemic area.

P2860

Q24308236-45653C64-9CB7-4996-894C-4A94BC098082 Q24633009-33D11E20-DB43-4333-A90E-442AD98ED22A Q24792748-5F2583E7-C5F5-4D53-8FEE-181CAE5FA7B5 Q24803786-6675424D-191B-42FD-8AC9-C0BB03ED7F7D Q24808841-213D89F9-5870-46CC-B70B-664099C59DFA Q26744347-5411157E-3257-4401-9E68-082740AE01EB Q26752374-1CC1ED26-2F98-49E8-B324-73FEE23FC6AC Q26861559-592A0DBC-699F-4603-9808-5807B237CAC4 Q26991976-4A925E9D-8166-44B4-BB1A-60113314DD71 Q26995677-04F3B527-820C-4C24-A391-489EF3209CE5 Q27016571-44CA89A9-89FC-45F5-9203-1798968389D3 Q28067631-716CE6BD-D9E9-4E8B-B5DC-6423FBEE7DB9 Q28073874-B66EBD17-3D4C-4ABD-B8FE-320EC8B2B54F Q28386921-C4F281C5-EF56-47D6-81F4-8727B938DB39 Q28476155-CFB6DCA5-3D60-428D-85F3-7597B1BC6166 Q28481311-4F515294-A5B0-4AE5-BEBA-32FCC9BE4A85 Q28540939-A2832D22-1E2A-47BC-8547-4D5334B84159 Q28648083-C202E94D-98A1-4664-A221-D1D2785BF31A Q30416228-E52A41FF-EEC6-404D-8441-194FD206CF2D Q30426606-1F532FE7-2D5E-443A-A3A3-1E687985465F Q30724968-19CD5C21-8646-4236-BE5B-19555DE5C57E Q30832187-3B44EE50-6D82-409A-9BFA-878D466A58F5 Q31013320-68F8F7F2-4D44-42DB-B14B-9DC8785825B3 Q33479161-DA3CDF6E-4EF7-443B-81E0-EE9F810F3C5E Q33508227-71B1032E-9B0D-4E13-AF2A-04849E844D89 Q33591239-0DDED6D1-863A-4EEC-A9DE-672DB2E11B20 Q33605532-8974568A-4278-4833-A233-E3EB8ABE84C4 Q33631960-E82A1B5A-B126-44EF-9AFF-A7EE0EB4B58B Q33643965-79DCA02D-A6EF-4B57-A992-527F62FD7819 Q33670036-10CB8C9F-6E3D-43FE-A2B0-94D78AFD3BF7 Q33688398-63A4882D-FA72-48E7-AB6E-354355903625 Q33718826-184BFEBE-3AF2-4DC5-AA0C-84C1113B0D4D Q33738154-D80035DE-0EF3-4ECA-B5C1-319F1259442B Q33745353-B801EF57-3859-43C4-A07B-0697CD82C8F6 Q33782386-5DAB8E0B-ABB3-49A6-9179-B1331C5A5544 Q33890583-87E0AB4C-E305-4D66-A4DF-606D68CE5C0B Q33907311-12A74AC0-8E19-4ACD-827D-AFD6A6E7332F Q34001166-55EC8A8D-07A7-4D2F-8301-93F887595130 Q34025160-CCC19CC7-000C-4F4B-A67A-70E270A1B877 Q34097257-E6EB75DC-EC8A-41E2-B7B0-148ACF955B8F

P2860

Antitumor and antimetastatic activity of interleukin 12 against murine tumors.

http://www.wikidata.org/entity/Q41906195

description

1993 nî lūn-bûn

@nan

1993年の論文

@ja

1993年論文

@yue

1993年論文

@zh-hant

1993年論文

@zh-hk

1993年論文

@zh-mo

1993年論文

@zh-tw

1993年论文

@wuu

1993年论文

@zh

1993年论文

@zh-cn

name

Antitumor and antimetastatic activity of interleukin 12 against murine tumors.

@en

type

label

Antitumor and antimetastatic activity of interleukin 12 against murine tumors.

@en

prefLabel

Antitumor and antimetastatic activity of interleukin 12 against murine tumors.

@en

P1433

Q41906195-C33C7F6B-E3E1-4B08-A734-B602F45B344E

P1476

Q41906195-B83AB1A7-8862-47D8-B444-9065565E49D0

P2093

Q41906195-27D2F4FC-6C87-4182-966B-F3D22563C84E

Q41906195-2CB36373-E885-47F4-A5D8-960587A27D6E

Q41906195-2F0430BE-381E-41CB-88F3-301C3EE0EB04

Q41906195-45AEA8A1-D223-448D-8492-7A2E98E45F03

Q41906195-648CF305-7F2F-40AB-83B2-0386ED5F187E

Q41906195-AE2BA8B2-D5D1-4D7D-9F1F-CBCB0774A8CF

Q41906195-BFA52AB4-E7A9-4038-8B16-685332500F5E

Q41906195-F1626888-CC1E-41EA-A2B8-C0CCA2433168

P2860

Q41906195-0007AE78-2155-4208-8253-96C62B3301E1

Q41906195-1BF1FE62-39DC-4C2D-A630-A95059BDEF3D

Q41906195-21DF9DBF-5A4E-49DD-B6FA-35D4FCE5E3E3

Q41906195-2F74914E-1279-4243-91FA-8CC87C1437D5

Q41906195-3F15DC4F-F4E4-4271-B058-AEAD828EC8DC

Q41906195-3FCAAAE6-9004-461C-841F-04D9171B96BC

Q41906195-41CAFBE1-A08F-46D3-A9AE-50824E727C6F

Q41906195-430D914B-8E15-4AA3-9F2E-445A318E455E

Q41906195-453CC110-EBD7-4128-B639-3F86ACB3D704

Q41906195-45F875D7-AF65-44A3-B3B5-0D443980AA72

P304

Q41906195-C8EE4395-F23E-409A-9A97-2CA90ABAC736

P31

Q41906195-6EBE5121-D46C-428C-8840-3513CE5FAAB1

P356

Q41906195-87C90226-33AB-4DE7-97E5-887F57BE5158

P407

Q41906195-EB435A40-54CA-48A1-A165-22710FE88407

P433

Q41906195-FE7D8B5E-1FFA-4FE5-9A15-FB5C08B7D2F6

P478

Q41906195-5642EE1B-C49B-4B28-85E6-7120CB0A4A38

P577

Q41906195-73D29BDB-F6AC-4F71-818A-6EE1DD57BD7B

P5875

Q41906195-104B8C3A-9D96-4C9D-95D5-C50E822B9694

P698

Q41906195-CCD86684-380D-487E-9511-3FD1C1E1547E

P932

Q41906195-80AED31B-CDC0-4FDD-A749-A73A8F20B8A5

P356

P1433

Journal of Experimental Medicine

P1476

Antitumor and antimetastatic activity of interleukin 12 against murine tumors.

@en

P2093

Brunda MJ

http://www.w3.org/2001/XMLSchema#string

Gately MK

http://www.w3.org/2001/XMLSchema#string

Hubbard BR

http://www.w3.org/2001/XMLSchema#string

Luistro L

http://www.w3.org/2001/XMLSchema#string

Murphy M

http://www.w3.org/2001/XMLSchema#string

Warrier RR

http://www.w3.org/2001/XMLSchema#string

Wolf SF

http://www.w3.org/2001/XMLSchema#string

Wright RB

http://www.w3.org/2001/XMLSchema#string

P2860

Purification to homogeneity and partial characterization of cytotoxic lymphocyte maturation factor from human B-lymphoblastoid cells

Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells

Coexpression of two distinct genes is required to generate secreted bioactive cytotoxic lymphocyte maturation factor

Multiple defects of immune cell function in mice with disrupted interferon-gamma genes

Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages

Cloning and expression of murine IL-12.

Cancer immunotherapy: are the results discouraging? Can they be improved?

Interleukin 7 induces CD4+ T cell-dependent tumor rejection.

Response of human natural killer (NK) cells to NK cell stimulatory factor (NKSF): cytolytic activity and proliferation of NK cells are differentially regulated by NKSF.

Interleukin 12 and tumor necrosis factor alpha are costimulators of interferon gamma production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist.

P304

1223-1230

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1084/JEM.178.4.1223

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

178

http://www.w3.org/2001/XMLSchema#string

P577

1993-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

275109033

http://www.w3.org/2001/XMLSchema#string

P698

8104230

http://www.w3.org/2001/XMLSchema#string

P932

2191194

http://www.w3.org/2001/XMLSchema#string